Almost 2.7 million people in the UK suffer from coronary heart disease (CHD), which kills 88,000 people every year, most of these being caused by heart attacks. Every year, about 124,000 heart attacks occur in the UK. In an award-winning British Heart Foundation (BHF) research project, scientists from Edinburgh ...

Piramal Imaging SA, a newly formed subsidiary of Piramal Healthcare Limited, announced positive first results from a Phase III study that showed that PET imaging with florbetaben reliably detects beta-Amyloid in the brain during life with great accuracy and thus shows value as a potential tool to aid in the ...

Amyvid (Florbetapir F 18 Injection), a medication for PET (Positron Emission Tomography) brain scans of adults, which estimates brain amyloid plaque content in patients with cognitive decline, has been approved by the Food and Drug Administration. Cognitive decline occurs when the patient finds it harder to think and form clear, ...

An early Positron Emission Tomography (PET) response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center. Prior studies by this multidisciplinary team of physician scientists at the ...

(University of California - Los Angeles Health Sciences) An early Positron Emission Tomography response after the initial cycle of neoadjuvant chemotherapy can be used to predict increased survival in patients with soft tissue sarcomas.

Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET scan, are not useful to establish the diagnosis of Alzheimer's disease. They arrived at this conclusion after analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), ...

Seven Asiatic black bears kept as pets in small cages will be prepared for a return to the wild in Vietnam after their owner decided they were too big for captivity, an official said Monday.

Imaging amino acid transporters with positron emission tomography/computed tomography (PET/CT) has been shown to significantly alter intended management plans for patients with brain tumors, according to research in the March issue of The Journal of Nuclear Medicine. As a result of imaging with the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-l-phenylalanine (F-18-DOPA), physicians changed the ...

Reston, Va. (March 1, 2012) Imaging amino acid transporters with positron emission tomography/computed tomography (PET/CT) has been shown to significantly alter intended management plans for patients with brain tumors, according to research in the March issue of The Journal of Nuclear Medicine . As a result of imaging ...

(Society of Nuclear Medicine) Imaging amino acid transporters with positron emission tomography/computed tomography has been shown to significantly alter intended management plans for patients with brain tumors, according to research in the March issue of the Journal of Nuclear Medicine. As a result of imaging with the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine, physicians ...

(Medical Xpress) -- Scientists at Washington University School of Medicine are using a new imaging device that simultaneously performs positron-emission tomography (PET) and magnetic resonance imaging (MRI) scans, producing more detailed images than either technique alone.

In two new studies featured in the February issue of The Journal of Nuclear Medicine, researchers are revealing how molecular imaging can be used to solve mysteries about difficult cases of breast cancer. One article focuses on an imaging agent that targets estrogen receptors in estrogen receptor-positive breast cancer patients ...